Please assess the completion status of the following clinical trial:

Trial Title: Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must be women 18 years and older who have biopsy proven endometrial or cervical carcinoma (of any histologic subtype).~* Surgical staging with the da Vinci Si robotic tool must be planned with a planned pelvic and, in the case of endometrial cancer, a para-aortic lymphadenectomy~* Patients must meet criteria for robotic surgical approach:~* Patients must have either a clinical stage I endometrial (of any histologic grade) or FIGO stage IA2 or IB1 (\<4cm) cervical squamous, adenocarcinoma or adenosquamous carcinoma.~* Patients must be able to sign an informed consent in English language.~* Patients with known liver disease will require normal range liver function tests as determined by pre-operative labs drawn within 30 days of surgery.~Exclusion Criteria:~* Patients who have iodide allergies~* Patients who have had previous retroperitoneal surgery~* Patients on whom pelvic+/- para-aortic lymphadenectomy is not planned as part of their surgical staging.~* Patients who have received previous treatment for their endometrial or cervical cancer (particularly hysterectomy or pelvic radiation).~* Patients who are pregnant.~* Patients with documented liver disease who have abnormalities of liver function tests.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- IC Green Arm (Type: EXPERIMENTAL): One arm only: Receives IC Green for testing of study objective

Based on this trial design, predict the completion outcome and termination type (if applicable).